ATE496031T1 - ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR - Google Patents

ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR

Info

Publication number
ATE496031T1
ATE496031T1 AT07728098T AT07728098T ATE496031T1 AT E496031 T1 ATE496031 T1 AT E496031T1 AT 07728098 T AT07728098 T AT 07728098T AT 07728098 T AT07728098 T AT 07728098T AT E496031 T1 ATE496031 T1 AT E496031T1
Authority
AT
Austria
Prior art keywords
treatment
dopamine
receptor
modulation
compounds suitable
Prior art date
Application number
AT07728098T
Other languages
German (de)
Inventor
Roland Grandel
Wilfried Martin Braje
Andreas Haupt
Sean Colm Turner
Udo Lange
Karla Drescher
Liliane Unger
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Priority claimed from PCT/EP2007/053633 external-priority patent/WO2007118859A1/en
Application granted granted Critical
Publication of ATE496031T1 publication Critical patent/ATE496031T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to aryloxyethylamine compounds of the formula (I) and the physiologically tolerated acid addition salts thereof. The variables have the meanings given in the claims and the description. The invention also relates to the use of a compound of the formula (I) or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.
AT07728098T 2006-04-14 2007-04-13 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR ATE496031T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06007923 2006-04-14
US79367106P 2006-04-20 2006-04-20
PCT/EP2007/053633 WO2007118859A1 (en) 2006-04-14 2007-04-13 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor

Publications (1)

Publication Number Publication Date
ATE496031T1 true ATE496031T1 (en) 2011-02-15

Family

ID=40631425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07728098T ATE496031T1 (en) 2006-04-14 2007-04-13 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR

Country Status (6)

Country Link
CN (1) CN101421243B (en)
AT (1) ATE496031T1 (en)
DE (1) DE602007012071D1 (en)
ES (1) ES2360254T3 (en)
PE (1) PE20080057A1 (en)
TW (1) TWI400233B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW450954B (en) * 1998-05-14 2001-08-21 Pharmacia & Amp Upjohn Company Phenylsulfonamide-phenylethylamines useful as dopamine receptors
EP1495004A2 (en) * 2002-02-13 2005-01-12 Glaxo Group Limited Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands
GB0411421D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
CN101421243A (en) 2009-04-29
DE602007012071D1 (en) 2011-03-03
CN101421243B (en) 2012-05-30
TW200808727A (en) 2008-02-16
ES2360254T3 (en) 2011-06-02
TWI400233B (en) 2013-07-01
PE20080057A1 (en) 2008-03-10

Similar Documents

Publication Publication Date Title
EA201200318A1 (en) Heterocyclic oximes
MY148258A (en) Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
EA021275B9 (en) Heterocyclic compounds, pharmaceutical composition comprising same and use thereof for treatment of pask-mediated disease
SI2150530T1 (en) Substituted sulfonamide derivatives
UA109698C2 (en) AZAINDASOL OR DIAZAINDASOL DERIVATIVES AS A MEDICINE
NZ600207A (en) Substituted 4-aminocyclohexane derivatives
EA201200260A1 (en) HETEROCYCLIC HYDRAZONES AND THEIR APPLICATION FOR THE TREATMENT OF CANCER AND INFLAMMATION
EA201101671A1 (en) SUBSTITUTED DERIVATIVES OF AMINOPROPIONIC ACID AS NEPRILISIN INHIBITORS
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
GB0722077D0 (en) Compounds
MX2008013212A (en) 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors.
UY31676A1 (en) "DERIVATIVES OF 3-METHYL-IMIDIAZO- [1,2-B] -PIRIDAZINA"
EA201270492A1 (en) COMPOUNDS FOR THE TREATMENT OF DISLIPIDEMIC AND RELATED DISEASES
EA201792597A2 (en) GLUTARIMIDES DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS OF THEIR PRODUCTION
ATE473221T1 (en) 1-(1-BENZYLPIPERIDINE-4-YL)BENZIMIDAZOLE-5-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS
IN2012DN00953A (en)
UY30284A1 (en) APPROPRIATE ARYLOXYETHYLAMINE COMPOUNDS TO TREAT DISORDERS RESPONDING TO DOPAMINE D3 RECEPTOR MODULATION
ATE502008T1 (en) AMINOMETHYL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIVE TO MODULATION OF THE DOPAMINE D3 RECEPTOR
MX2009013482A (en) [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases.
GEP20125526B (en) Drug active in neuropathic pain
SG10201809506TA (en) Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
DE602005001918D1 (en) S-TENATOPRAZOLNATRIUM MONOHYDRATE SALT AND ITS USE IN THE FORM OF A PROTON PUMPING MASTER
ATE540922T1 (en) AMINOETHYL AROMATIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIVE TO MODULATION OF THE DOPAMINE D3 RECEPTOR
ATE496031T1 (en) ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR
EA201070478A1 (en) DIPHENYL CARBONIC ACIDS AND THEIR DERIVATIVES

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties